GAMCO INVESTORS, INC. ET AL - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$2,649,000
+15.7%
61,300
+13.1%
0.02%
+41.7%
Q2 2015$2,290,000
+3.2%
54,200
-5.2%
0.01%0.0%
Q1 2015$2,218,000
+15.2%
57,2000.0%0.01%
+20.0%
Q4 2014$1,926,000
-3.8%
57,2000.0%0.01%
-9.1%
Q3 2014$2,003,000
+6.5%
57,2000.0%0.01%
+10.0%
Q2 2014$1,880,000
-14.6%
57,200
-4.2%
0.01%
-16.7%
Q1 2014$2,201,000
-12.0%
59,700
-8.4%
0.01%
-7.7%
Q4 2013$2,502,000
+5.4%
65,200
-24.7%
0.01%
-7.1%
Q3 2013$2,373,000
-3.5%
86,600
-26.0%
0.01%
-6.7%
Q2 2013$2,459,000117,1000.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders